We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News   Nov 18, 2020

 
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Credit: CDC/ Unsplash

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Optibrium Enhances Compound Design Strategies

Product News

Optibrium™ today announced the release of the newest version of StarDrop™, a comprehensive software platform for small molecule design, optimisation and data analysis.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

Thermo Extends SARS-CoV-2 Program to Support Research on New Virus Strains

Product News

Company makes subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE